Otolith Labs
11
0
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.2%
2 terminated/withdrawn out of 11 trials
71.4%
-15.1% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Effect of Bone-Conducted Stimulation on Rotary Chair Time Constants in Patients With Vestibular Migraines
Role: lead
Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting
Role: lead
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand
Role: lead
Efficacy of a Transcranial Vibrating System for Minimizing Dizziness During Caloric Testing
Role: lead
SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines
Role: lead
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
Role: lead
Transcranial Vibrating System for Improving Vestibular Physical Therapy
Role: lead
Evaluation of the OtoBand as a Treatment to Reduce the Perceived Loudness of Tinnitus
Role: lead
Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy
Role: lead
Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo
Role: lead
Prevention of Unmitigated Chemotherapy-induced Emesis
Role: lead
All 11 trials loaded